What is Melanotan I?
Melanotan 1, also known as afamelanotide or NDP-MSH, is a synthetic analogue of α-melanocyte-stimulating hormone (α-MSH) developed for research involving melanocortin receptor signaling. It is studied primarily in relation to melanocortin receptor 1 (MC1R), a receptor commonly investigated in pigmentation biology, photobiology, and melanocortin-system research.
Structurally, Melanotan I incorporates modifications to the native α-MSH sequence that provide improved stability in experimental systems, making it a widely used tool in melanocortin receptor studies.
In the scientific literature, Melanotan I is frequently used in investigations of melanogenesis-associated signaling pathways, MC1R pharmacology, ultraviolet (UV) response mechanisms, and pigment-cell biology. Researchers employ it as a reference compound for examining how melanocortin receptor activation relates to cellular signaling processes within controlled experimental models.
Current mechanistic understanding is derived primarily from receptor pharmacology studies, in vitro experiments, animal models, and translational research involving melanocortin-system signaling.
Melanotan I vs α-MSH vs Melanotan II
Melanotan 1 is often discussed alongside endogenous α-MSH and other melanocortin analogues, particularly Melanotan II, in studies evaluating receptor selectivity, signaling characteristics, and pharmacological properties.
Compared with native α-MSH, Melanotan I provides a more stable and experimentally practical model for investigating melanocortin receptor signaling. Compared with Melanotan II, Melanotan I is generally utilized in research focused on MC1R-associated signaling and pigmentation-related pathways, whereas Melanotan II is more commonly studied in relation to broader melanocortin receptor activity across multiple receptor subtypes.
This distinction makes Melanotan I particularly useful for investigations centered on MC1R pharmacology, pigment-cell signaling, and photobiology within controlled laboratory environments.
Bluum Peptides supplies Melanotan I as a high-purity lyophilized research compound manufactured to support reproducible experimental outcomes. Each batch undergoes independent third-party analytical verification, with lot-specific Certificates of Analysis (COAs) available to confirm identity, purity, and batch consistency.
Melanotan I is supplied strictly for research use only and is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications.
Melanotan I Mechanism of Action (Research Only)
Melanotan I is a synthetic melanocortin receptor agonist studied primarily in relation to melanocortin receptor 1 (MC1R) signaling. It serves as a well-characterized research tool for investigating melanocortin-system activity, receptor pharmacology, pigmentation-associated signaling pathways, and photobiology.
Current mechanistic understanding is derived largely from receptor pharmacology studies, in vitro experiments, animal models, and translational research involving skin-cell biology.
Structural and Chemical Basis
Melanotan I is a modified analogue of α-melanocyte-stimulating hormone (α-MSH) developed to provide a more stable model for investigating melanocortin receptor signaling. Structural modifications to the native peptide sequence contribute to its utility in experimental systems and have made it one of the most widely studied compounds in melanocortin receptor research [1].
These characteristics allow researchers to examine receptor-mediated signaling pathways using a well-defined melanocortin ligand with extensive representation in the scientific literature.
MC1R Activation and Receptor Signaling
The primary signaling pathway associated with Melanotan I involves interaction with melanocortin receptor 1 (MC1R), a receptor commonly studied in pigment-cell biology and photobiology research. Experimental models use MC1R signaling to investigate how melanocortin receptor activation relates to intracellular communication pathways and downstream cellular responses [2].
Because MC1R is one of the most extensively studied receptors within the melanocortin system, Melanotan I has become a standard reference compound for examining receptor activity and melanocortin-mediated signaling processes.
cAMP-Associated Signaling Pathways
Research involving Melanotan I frequently examines intracellular signaling pathways associated with MC1R activation, including cyclic AMP (cAMP)-related signaling processes. These pathways are commonly studied to understand how receptor-level signaling events are translated into broader cellular responses within experimental models.
Investigations of cAMP-associated signaling contribute to a broader understanding of melanocortin receptor pharmacology, signal transduction, and pathway regulation.
Pigmentation and Photobiology Research
Melanotan I is widely utilized in studies involving pigmentation-associated signaling pathways and photobiology. Researchers use experimental models to investigate relationships among melanocortin receptor activity, pigment-cell signaling, ultraviolet (UV) response mechanisms, and cellular adaptation processes within controlled laboratory environments.
These applications have made Melanotan I one of the most commonly referenced compounds in research involving melanocortin-system signaling and skin-cell biology.
Receptor Selectivity and Comparative Research
Melanotan I is frequently evaluated alongside other melanocortin ligands in studies examining receptor selectivity, signaling characteristics, and pathway interactions. Comparative research uses these models to investigate differences among melanocortin receptor agonists and to better understand how receptor preference may influence signaling behavior within experimental systems.
This has established Melanotan I as a valuable reference compound for melanocortin receptor pharmacology and melanocortin-system research.
Melanotan I is supplied strictly for laboratory research use and serves as a tool for investigating melanocortin receptor signaling, pigmentation-associated pathways, and photobiology. It is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications.
Melanotan I Research Applications (Observations from Studies)
Melanotan I has been studied across preclinical, translational, and receptor-pharmacology research settings as a model melanocortin analogue for investigating MC1R-associated signaling pathways, pigmentation biology, and photobiology. Much of its research value stems from its extensive use in studies examining melanocortin receptor activity, pigment-cell signaling, ultraviolet (UV) response mechanisms, and related cellular signaling processes.
The findings referenced below reflect observations from controlled research environments and should be interpreted within that context. They should not be construed as clinical outcomes or as applicable to human or veterinary use.
Melanogenesis and Pigmentation Signaling
One of the primary research applications of Melanotan I involves studies of melanogenesis-associated signaling pathways and pigment-cell biology. Experimental models use Melanotan I to investigate how MC1R activation relates to intracellular signaling events, pigment-cell activity, and melanocortin-mediated communication processes [2].
Researchers frequently employ Melanotan I as a reference compound when studying pigmentation-associated signaling because its receptor profile and extensive characterization in the scientific literature provide a consistent framework for experimental investigation.
Photobiology and UV-Response Research
Melanotan I is widely utilized in photobiology research involving melanocortin signaling and ultraviolet (UV) response pathways. Experimental studies examine relationships among receptor activity, pigment-cell signaling, UV-associated cellular processes, and broader photobiological mechanisms [3].
These applications have established Melanotan I as a commonly used research tool for investigating how melanocortin-system signaling interacts with cellular pathways studied in photobiology and skin-cell research.
MC1R Pharmacology and Receptor Biology
Because Melanotan I is one of the most extensively studied α-MSH analogues, it is frequently used as a reference ligand in melanocortin receptor pharmacology. Researchers compare it with endogenous melanocortins, MC1R-focused ligands, and broader melanocortin receptor agonists to investigate receptor interactions, signaling characteristics, pathway activity, and ligand behavior within experimental systems.
These studies contribute to a broader understanding of MC1R pharmacology and have made Melanotan I a widely recognized reference compound in receptor-based research.
Comparative Research with Other Melanocortin Ligands
Melanotan I is frequently evaluated alongside Melanotan II and other melanocortin analogues in comparative receptor-pharmacology studies. These investigations examine differences in receptor profiles, signaling characteristics, and pathway interactions across various melanocortin compounds.
Such comparative models help researchers select appropriate tools for studies focused on MC1R-associated signaling, pigmentation-related pathways, photobiology, or broader melanocortin-system investigations.
Melanotan I vs Melanotan II vs α-MSH
Compound selection in melanocortin research often comes down to three practical questions: how broad is the receptor profile, how stable is the compound under experimental conditions, and is the study centered on pigmentation specifically or on wider melanocortin biology?
The comparison below addresses those questions directly, positioning Melanotan I alongside Melanotan II and endogenous α-MSH to support assay planning and inform literature-based decision-making.
| Feature | Melanotan I (Afamelanotide / NDP-MSH) | Melanotan II | α-MSH |
|---|---|---|---|
| Classification | Synthetic α-MSH analogue | Synthetic cyclic melanocortin analogue | Endogenous melanocortin peptide hormone |
| Main research emphasis | Melanogenesis, photobiology, MC1R-linked signaling | Broader melanocortin-system studies with pigment relevance | Baseline endogenous melanocortin signaling |
| Receptor scope | Melanocortin agonist with strongest practical association to MC1R-centered pigment research | Broader melanocortin receptor activity, including non-pigment receptors | Endogenous melanocortin activity across melanocortin receptors |
| Stability | More stable and experimentally useful than native α-MSH | Potent and stable cyclic design | Shorter-lived native ligand |
| Research need | When the study centers on pigmentation, melanogenesis, or photobiology | When broader melanocortin signaling is part of the design | When the experiment needs the native physiological reference ligand |
| Research-use context | Research peptide | Research peptide | Endogenous signaling standard / research comparator |
Melanotan I is frequently used as a reference compound in studies examining melanocortin receptor pharmacology, particularly when research objectives involve MC1R-associated signaling and pigmentation-related pathways. It occupies a distinct position within the melanocortin literature due to its extensive characterization and widespread use in photobiology, pigment-cell biology, and receptor-signaling research.
Newer melanocortin ligands and receptor-selective compounds may be utilized in studies with specific receptor-pharmacology objectives, while endogenous α-MSH continues to serve as an important physiological reference molecule. Melanotan I remains one of the most widely cited and extensively studied melanocortin ligands in experimental research involving MC1R signaling and melanocortin-system biology.
Selection of a research compound ultimately depends on the objectives of the study, the signaling pathways being investigated, and the receptor systems of interest. Melanotan I supplied by Bluum Peptides is intended strictly for laboratory research use and is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications.
Melanotan I Laboratory Safety & Handling
Melanotan I is supplied as a lyophilized research peptide and should be handled in accordance with established laboratory practices for biologically active research materials. Proper storage, documentation, and handling procedures are important for maintaining material integrity and supporting consistency across experimental workflows.
As with other peptide-based research compounds, Melanotan I may be affected by environmental factors such as moisture, excessive light exposure, temperature fluctuations, and repeated handling. Appropriate laboratory controls should be used to minimize contamination and preserve sample integrity throughout storage and experimental use.
Laboratory Handling Considerations
Melanotan I should be handled using standard laboratory procedures appropriate for lyophilized peptide materials.
- Follow institutional standard operating procedures (SOPs), chemical hygiene plans, and approved research protocols
- Wear appropriate personal protective equipment (PPE), including gloves, laboratory coat, and eye protection
- Perform weighing and handling procedures in controlled laboratory environments where appropriate to minimize contamination and environmental exposure
- Handle powders carefully to reduce airborne particulates and avoid contact with skin, eyes, and mucous membranes
- Maintain accurate records of lot numbers, preparation dates, and related research documentation to support traceability and reproducibility
- Utilize suitable laboratory containers and equipment to support sample integrity during handling and storage
These practices help support consistency across receptor-pharmacology, pigment-cell biology, and melanocortin-system research applications.
Storage and Stability Considerations
Appropriate storage conditions are important for maintaining the integrity of lyophilized peptide materials during research use.
- Store material according to product documentation and laboratory protocols
- Protect from excessive heat, light, moisture, and unnecessary environmental stress during storage and handling
- Maintain consistent storage conditions across experiments to support reproducibility
- Minimize repeated freeze–thaw exposure and other conditions that may affect material integrity
- Inspect materials and associated documentation prior to use as part of routine laboratory quality-control procedures
Proper storage and handling practices help reduce avoidable sources of variability and support consistency across experimental workflows.
Melanotan I is supplied strictly for research use only. Bluum Peptides does not provide medical, diagnostic, or therapeutic guidance regarding this compound. This material is not intended for human consumption, veterinary use, diagnosis, treatment, or therapeutic application and must be handled exclusively within qualified laboratory settings.
Certificate of Analysis (COA) & Quality Assurance
Each lot of Melanotan I supplied by Bluum Peptides is accompanied by a third-party-verified Certificate of Analysis to support reproducibility, traceability, and data integrity in research use. Third-party testing is conducted by leading analytical labs, particularly Janoshik Analytical and BioRegen, and each COA includes identity, purity, and composition-related verification as per test results.
The certificates also include batch and lot tracking on product pages, which is useful for researchers that need tighter material control across multiple runs or repeat orders.
COAs typically include:
● Identity verification using analytical techniques such as mass spectrometry or equivalent peptide-confirmation methods
● Purity assessment, commonly by HPLC or comparable chromatographic analysis
● Composition or sequence-related confirmation where applicable
● Lot number, report date, and analytical documentation that supports traceability and reproducibility
Bluum Peptides provides a full Certificate of Analysis with every product, giving researchers direct access to batch-specific identity, purity, and potency data. In laboratory research use, standard procedure is to retain the COA alongside internal records so that the exact batch used in any given experiment can be referenced during audits, troubleshooting, replication efforts, or procurement review.
Scientific References
- Böhm M, Robert C, Malhotra S, Clément K, Farooqi S, An overview of benefits and risks of chronic melanocortin-1 receptor activation, Journal of the European Academy of Dermatology and Venereology, 2025 Jan;39(1):39–51, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664455/
- García-Borrón JC, Abdel-Malek Z, Jiménez-Cervantes C, MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation, Pigment Cell & Melanoma Research, 2014 Sep;27(5):699–720, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150834/
- Abdel-Malek ZA, Knittel J, Kadekaro AL, Swope VB, Starner R, The melanocortin 1 receptor and the UV response of human melanocytes-a shift in paradigm, Photochemistry and Photobiology, 2008 Mar–Apr;84(2):501–508, https://onlinelibrary.wiley.com/doi/full/10.1111/j.1751-1097.2008.00294.x
